Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Nasopharyngeal Carcinoma 2Glioma 2Glioblastoma 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Resectable Lung Non-Small Cell Carcinoma 1Radiation Injuries 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lung Neoplasms 1Gastroesophageal Junction Adenocarcinoma 1Frailty 1Chordoma 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Astrocytoma 1

Interventions

Carboplatin 195Cisplatin 117Paclitaxel 107Pemetrexed 106Docetaxel 96Gemcitabine 89Radiotherapy 83Erlotinib Hydrochloride 58Bevacizumab 55Etoposide 49durvalumab 39pembrolizumab 38Nivolumab 31Specimen Handling 30Magnetic Resonance Spectroscopy 30Irinotecan 27Radiosurgery 26osimertinib 24Gefitinib 24Drug Therapy 23Vinorelbine 22atezolizumab 20Topotecan 20Radiation 16Cetuximab 16Taxes 15Surgical Procedures, Operative 14Neoadjuvant Therapy 13Filgrastim 13Chemotherapy, Adjuvant 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lung Neoplasms × Protons × Clear all
NCT03132532 2025-11-25

Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Mayo Clinic

Phase 2 Completed
20 enrolled 20 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡